Abstract Primary diffuse leptomeningeal gliomatosis (PDLG) is a rare central nervous system neoplasm in which gliomatous tissue is diffusely identified in the subarachnoid space with no evidence of a primary intraparenchymal tumor. A 52-year-old man presented low back pain followed by sudden unconsciousness and had also cognitive dysfunction and meningeal sign. Examinations of cerebrospinal fluid (CSF) did not show malignant cells but increased protein and pleocytosis. Magnetic resonance (MR) imaging demonstrated diffuse leptomeningeal enhancement without any source of intraparenchymal lesion. Fluid-attenuated inversion recovery (FLAIR) also demonstrated individual diffuse high intensity area in the subarachnoid space. A biopsy disclosed wide spreading of anaplastic glial cells within the leptomeninges. He died 3 months later because of disease progression despite both radiotherapy and chemotherapy. Post-mortem examination identified PDLG and several neuropathological features of glioblastoma as well. Reviewing previous cases of PDLG instructs that this entity is rare, resembles meningitis in clinical pictures, usually occurs in a relatively younger population and has more progressive clinical course than the ordinary form of malignant gliomas.
Introduction
Widespread seeding in the subarachnoid space of gliomatous tumors is an uncommon condition, which has been called meningeal gliomatosis. It is composed of two subtypes, primary and secondary type. The latter is known as secondary glial spread from a primary intraparenchymal focus, while the former is even rare and characterized by arising from heterotopic glial nests without evidence of tumor within the parenchyma of the brain and spinal cord [1] . A number of cases of primary diffuse leptomeningeal gliomatosis (PDLG) have been so far reported in the literature . We report a case of PDLG diagnosed during life and verified at autopsy and discuss clinical characteristics, neuroradiological and histopathological findings and treatment to the previously described cases.
Case report
Clinical course: A 52-year-old man who had had a history of alcohol addiction requiring several hospitalization, noticed a gradual onset of low back pain and numbness of bilateral legs. He consulted a local doctor; however, conservative care made no relief of his symptom. One month later he suddenly became unconscious accompanied with urinary incontinence, and was rushed to a regional general hospital. He presented with cognitive impairment, nuchal rigidity, papilledema and bilateral abducens palsy suggesting increased intracranial pressure (ICP). Computed tomography showed only mild brain atrophy with ventriculomegaly. Spinal tapping indicated that ICP was more than 30 cmH2O and aspirated cerebrospinal fluid (CSF) was xanthochromic. Cytochemical study showed moderately increased cell count with lymphocyte predominance and marked increase in protein up to 1560 mg/dl, with no definite evidence of neoplasm. Bacterial or viral meningitis or Wernicke's encephalopathy was initially suspected; however, administration of both antibiotics and thiamine had no clinical impact.
Two weeks later he was transferred to our hospital because of persisting symptoms such as low-grade fever and deteriorating confusion. Magnetic resonance (MR) imaging of the entire neuraxis did not indicate any nodular lesions but diffuse leptomeningeal enhancement, predominantly along the posterior cranial fossa and the lumbosacral spinal canal (Figs. 1A and 2 ). In addition, cervical spinal cord bulging was observed (Fig. 2) . Fluid-attenuated inversion recovery (FLAIR) images also demonstrated characteristic diffuse high intensity area in the subarachnoid space and the fourth ventricle (Fig. 1B) . The first biopsy of leptomeninges through a burr hole in the right frontal lobe did not confirm any neoplasm but non-specific neutrophil accumulation. Re-examination of drainaged CSF, bacteriological cultures and Polymerase chain reaction assay in order to detect Mycobacterium tuberculosis, was carried out with negative results. Subsequent neuropsychiatric deterioration despite ventricular drainage for coexisting non-obstructive hydrocephalus prompted histological reassessment. Open biopsy via right frontotemporal craniotomy was employed 2 weeks after the first operation. Intraoperatively the arachnoid membrane was obviously thickened but the brain surface looked normal. Specimens including cerebral parenchyma as well as leptomeninges were obtained from the basal cistern. Microscopically anaplastic astrocytic cells diffusely infiltrated into the subarachnoid space without parenchymal involvement. Immunohistochemical analyses indicated that GFAP, S-100 protein and vimentin were consistently positive for neoplastic cells and MIB-1 labeling index was approximately ten percent. It was histologically diagnosed as anaplastic astrocytoma. Treatment of irradiation to the whole neuraxis (total dose of 3000cGy) and chemotherapy with ranimustine and interferon has failed and the patient died due to respiratory arrest three months after the initial presentation.
Post-mortem examinations: There were numerous patchy or diffuse thickening of leptomeninges in the basal cistern, brain stem (Fig. 3A) and cerebellar hemisphere. Diffuse bulging was also observed in the whole spinal cord, especially in the cervical region. The caudal dural sac was totally stuffed with neoplastic cells and the cauda equina was immersed by the tumor (Fig. 3B) . Light microscopy revealed a diffuse extensive infiltration of anaplastic glial cells in the leptomeninges of the brain and spinal cord without an underlying parenchymal tumor (Fig. 4) . The superficial white mater of cervical spinal cord was, however, partly infiltrated by anaplastic cells, which seemed to be secondary intrusion of malignant cells. Necrosis, pseudopallisading, severe cell atypia and high mitotic activity were also observed. The immunohistochemical findings corresponded to those of the previous biopsy but MIB-1 labeling index was twice as much as it at the biopsy.
Discussion
PDLG is a tumor in which glial neoplastic cells diffusely infiltrated in the leptomeninges, with no evidence of primary neoplasia within the neuraxis [1] . The etiology of PDLG is still unclear. Cooper and Kernohan speculated that neoplastic cells of PDLG presumably arise within heterotopic leptomeningeal glial nests, which can be found in the subarachnoid space in approximate 1% of unselected necropsies, most commonly around the medulla oblongata, and 25% of autopsies with developmental neurological abnormalities [1] . It was postulated that during development glial cells might migrate from central nervous system through microscopic defects in the pia mater. The first case of PDLG was described by Roussy et al. [41] . Although a number of cases have been reported since then, this entity is still even rare. Many of those have been reported since 1990 and on the increase, probably because of easier detection of the lesion by radiological imaging innovation such as MR imaging [4, 6-10, 11, 14-16, 20, 22, 23, 25-29, 31, 33, 34, 35-38] . Our review of the literature produced 45 cases of PDLG with detailed observations for the last two decades and this review is the largest series of its kind to date. Table 1 shows summary of those presenting characteristic details such as age, sex, histopathology, treatment modality and prognosis. Patients' age at clinical presentation widely ranged from 1 to 80 years old with a median age of 34 years, which is relatively younger than patients with the solitary form of malignant astrocytic tumors [35, 42, 43] . The population of patients consisted of 22 men and 23 women, without gender predilection. The most common symptoms are meningeal sign, mental confusion, bilateral papilledema and multiple cranial and spinal nerve palsies suggesting intracranial hypertension or direct invasion of tumor cells to peripheral nerve in the subarachnoid space. These clinical manifestations of PDLG are very similar to those of infectious meningitis [3, 5, 8, 9, 11, 13, 16, 18, 20, 24, 30, 31, 36, 39] . Assay of CSF usually indicates marked increase in proteins associated with moderate pleocytosis and normal or low glucose level. This clinical picture is confusing and likely to lead to misdiagnosis as tuberculous or fungal meningitis. In about one-third of reviewed cases antituberculous drugs were administrated until the latter end because of difficulty in premortem diagnosis. Attention must be also paid for false negative in cytology because negative results in cytology are not infrequent as in our case (Table 1 ) [44] . In our review the cases with negative and positive results in initial CSF cytology were 36 and 1, respectively. Repetitive spinal tapping may be needed for the proper diagnosis even if the first tap failed to prove existence of neoplastic cells [10, 12, 30] . Hydrocephalus will be complicated in most cases because diffuse infiltration of neoplastic cells into the subarachnoid space probably compromise physiological circulation of CSF [3, 5, 6, 10, 11, 15, 16, 18, 20, 23, 24, 26, [29] [30] [31] 40] . Treatment for this secondary hydrocephalus consists of only external drainage or ventriculoperitoneal shunt, but the latter may potentially harbor the risk of dissemination to the intraperitoneal cavity that has never been reported yet. MR imaging of the brain and the spinal cord is very useful for early and proper diagnosis [4, 6, 8, 10, 11, 15, 16, 20, 22, 23, 26-29, 31, 33-38] . Diffuse leptomeningeal enhancement with no discernible intraaxial component is a pathognomonic finding. FLAIR sequence also had a characteristic finding of diffuse high intensities in the subarachnoid space as in the presented case, which is the first description as far as we could investigate in the reported literatures. This phenomenon is similar to FLAIR image of acute phase of subarachnoid hemorrhage and may be contributed by markedly elevated protein content and occupation of subarachnoid space by neoplastic cells. However, a meningeal biopsy appears to be the only definitive diagnostic approach. In our case the first biopsy was not diagnostic presumably due to our concern for minimal invasiveness. Attention must be paid for appropriate selection of location of biopsy because some authors also reported negative results even in biopsy of the affected leptomeninges [5] . The clinical course of PDLG is fairly poorer than that of the solitary form as other clinicians reported [3, 16] . Time between the first symptoms and death of most cases was less than 12 months and median survival interval in this review is 4 months (one day-78 months) ( Table 1) . Even if the diagnosis of PDLG was made promptly, clinical practitioners necessarily follow only conventional treatments applied for malignant gliomas. Although a few cases with longterm survival were reported in which whole CNS radiotherapy and/or various intensive chemotherapy were employed [10, 19, 21, 27, 31] , neither of them seemed to have adequate efficacy in many cases. Chamberlain reported a large series of intraventricular chemotherapy mainly using methotrexate for leptomeningeal gliomatosis secondary to high-grade gliomas. Partial response was achieved in only one-third of 18 patients and median survival time was just 3.5 months [45] . Recently efficacy of temozolomide for PDLG is reported. Franceschi et al. [15] described a case of a patient achieved partial response by combination of temozolomide and systemic chemotherapy. Arvan et al. [46] also reported two juvenile cases with more than 2 years survival, which are pilocytic astrocytomas with secondary diffuse leptomeningeal spread. Initial results of temozolomide may be encouraging, however, longer follow-up study of a larger cohort is necessary to demonstrate the efficient usage of temozolomide for PDLG. The high growth rate and the wide diffusion of the tumor at presentation may account for the poor prognosis. However, genetic background of growth pattern of PDLG is still unclear. Some researchers demonstrated the relationship between leptomeningeal dissemination and mutations of the tumor suppressor genes such as the p53 gene and the PTEN gene [8, 47] . However alterations of those genes are recognized not only in PDLG but also in many different human tumors. Histologically lowgrade astrocytomas have nearly equal distribution to high-grade astrocytomas such as anaplastic astrocytoma and glioblastoma multiforme (Table 1) . Histological grading, however, appears to have little relationship to prognosis in those reported cases [12, 26] . A few oligodendroglial tumors and each one case of ganglioglioma and ependymoblastoma were included in this review, whose clinical pictures are similar to other PDLG except its prevalence among children or adolescence [9, 10, 24, 32, 38, 39] . Although many cases of juvenile leptomeningeal dissemination secondary to pilocytic astrocytomas in hypothalamic-chiasmatic region have been reported, they seem to be somewhat different from PDLG as having primary neuraxial foci and favorable clinical course [48, 49] .
In conclusion, a case of primary diffuse leptomeningeal gliomatosis with histological features of glioblastoma was presented. Reviewing the literature demonstrated that biological behavior of PDLG is fairly different from the ordinary solid tumors. Pathognomonic aspects are inability to make a diagnosis because of its rarity and clinical resemblance to aseptic meningitis and its extensive and aggressive nature refractory to intensive radiotherapy and chemotherapy. Further studies are needed as to elucidate genetic background that must exist behind diffuse extension of 
